Aranthan Ii Jones - Net Worth and Insider Trading
Aranthan Ii Jones Net Worth
The estimated net worth of Aranthan Ii Jones is at least $443,512 dollars as of 2024-11-13. Aranthan Ii Jones is the Chief Corp. Affairs Officer of Vanda Pharmaceuticals Inc and owns about 81,980 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $443,512. Details can be seen in Aranthan Ii Jones's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aranthan Ii Jones has not made any transactions after 2021-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aranthan Ii Jones
Aranthan Ii Jones Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aranthan Ii Jones owns 1 companies in total, including Vanda Pharmaceuticals Inc (VNDA) .
Click here to see the complete history of Aranthan Ii Jones’s form 4 insider trades.
Insider Ownership Summary of Aranthan Ii Jones
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc | 2021-09-15 | Chief Corp. Affairs Officer |
Aranthan Ii Jones Latest Holdings Summary
Aranthan Ii Jones currently owns a total of 1 stock. Aranthan Ii Jones owns 81,980 shares of Vanda Pharmaceuticals Inc (VNDA) as of September 15, 2021, with a value of $443,512.
Latest Holdings of Aranthan Ii Jones
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc | 2021-09-15 | 81,980 | 5.41 | 443,512 |
Holding Weightings of Aranthan Ii Jones
Aranthan Ii Jones Form 4 Trading Tracker
According to the SEC Form 4 filings, Aranthan Ii Jones has made a total of 7 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 16,824 shares on September 15, 2021, which brought Aranthan Ii Jones around $277,428.
Insider Trading History of Aranthan Ii Jones
- 1
Aranthan Ii Jones Trading Performance
Aranthan Ii Jones Ownership Network
Ownership Network List of Aranthan Ii Jones
Ownership Network Relation of Aranthan Ii Jones
Aranthan Ii Jones Owned Company Details
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Aranthan Ii Jones is the Chief Corp. Affairs Officer of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include VP & Acting CFO & Treasurer Kevin Patrick Moran , SVP & General Counsel Timothy Williams , and director & Chief Executive Officer Mihael Hristos Polymeropoulos .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Aranthan Ii Jones made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 35,163 shares made by Kevin Patrick Moran , a net sale of 31,688 shares made by Timothy Williams , and a net sale of 20,451 shares made by Joakim Wijkstrom .
In summary, during the past 3 months, insiders sold 0 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 166,385 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,385 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
Aranthan Ii Jones Mailing Address
Above is the net worth, insider trading, and ownership report for Aranthan Ii Jones. You might contact Aranthan Ii Jones via mailing address: 2200 Pennsylvania Ave Nw, Suite 300e, Washington Dc Dc 20037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
